English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

The Leipzig treatment program for interdisciplinary diagnosis and therapy of neurocognitive post-COVID symptoms

MPS-Authors
/persons/resource/persons19903

Obrig,  Hellmuth
Clinic for Cognitive Neurology, University of Leipzig, Germany;
Department Neurology, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons19981

Schroeter,  Matthias L.
Clinic for Cognitive Neurology, University of Leipzig, Germany;
Department Neurology, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons20065

Villringer,  Arno       
Clinic for Cognitive Neurology, University of Leipzig, Germany;
Department Neurology, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons20048

Thöne-Otto,  Angelika I. T.
Clinic for Cognitive Neurology, University of Leipzig, Germany;
Department Neurology, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

Hasting_2023.pdf
(Publisher version), 2MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Hasting, A. S., Herzig, S., Obrig, H., Schroeter, M. L., Villringer, A., & Thöne-Otto, A. I. T. (2023). The Leipzig treatment program for interdisciplinary diagnosis and therapy of neurocognitive post-COVID symptoms. Zeitschrift für Neuropsychologie, 34(2), 71-83. doi:10.1024/1016-264X/a000376.


Cite as: https://hdl.handle.net/21.11116/0000-000D-4CDE-5
Abstract
This study introduces a 3-week group program designed for patients with neurocognitive post-COVID-19 syndrome (PCS). The program represents a combination of evidence-based components of neurorehabilitation and cognitive behavioral therapy (CBT). Following a detailed assessment, we develop a personalized bio-psycho-social model that integrates perceived complaints and identifies modifiable and influencing factors. We employed physiotherapeutic, cognitive, and communicative training methods to improve patients’ awareness of energy limits and implement compensatory strategies, including pacing and mindfulness techniques. N = 33 patients completed the program between June 2021 and November 2022. A pre-post comparison of questionnaire-based self-assessments revealed significant positive effects on mood, self-efficacy, and participation but not on fatigue symptoms. The study provides recommendations for the neuropsychological treatment of patients with PCS.